3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 3
3
Phase 4
2
Phase 2/3
2
Phase 1/2
2
Phase 1
2
Phase NA
1
Status
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
2
Sarcoma
1
Conditions
Neoplasms
2012
Carcinoma, Non-Small-Cell Lung
1228
Breast Neoplasms
1215
Leukemia, Myeloid, Acute
967
Neoplasm Metastasis
902
Melanoma
778
Colorectal Neoplasms
752
Multiple Myeloma
725
Lymphoma
725
Ovarian Neoplasms
675
Pancreatic Neoplasms
665
Lymphoma, Non-Hodgkin
659
Prostatic Neoplasms
657
Recurrence
637
Precursor Cell Lymphoblastic Leukemia-Lymphoma
585
Lung Neoplasms
560
Leukemia, Lymphocytic, Chronic, B-Cell
555
Glioblastoma
527
Leukemia
486
Lymphoma, Large B-Cell, Diffuse
440
Lymphoma, Follicular
419
Brain Neoplasms
415
Squamous Cell Carcinoma of Head and Neck
389
Stomach Neoplasms
387
Carcinoma, Renal Cell
385
Myelodysplastic Syndromes
382
Carcinoma, Hepatocellular
368
Advanced Solid Tumors
357
Lymphoma, Mantle-Cell
345
Glioma
343
Interventions
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Interventional
×
Lymphohistiocytosis, Hemophagocytic
×
Clear all
NCT00710892
2025-07-11
CASPALLO
Baylor College of Medicine
Phase 1
Active not recruiting
10 enrolled
NCT01494103
2025-07-11
DOTTI
Baylor College of Medicine
Phase 1
Active not recruiting
15 enrolled